The European Medicines Agency and European Commission are jointly developing Enhertu for market approval and seeking authorization in the EU.
2 reports, 1 independent
Updated Jul 24
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The European Medicines Agency and European Commission are jointly developing Enhertu for market approval and seeking authorization in the EU.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
European Medicines Agency
highest regulatory authority on medicines in the European Union
-
European Commission
executive branch of the European Union
-
Daiichi Sankyo
Japanese pharmaceutical company
-
AstraZeneca
British-Swedish pharmaceutical company